Universal Health Services Inc
NYSE:UHS

Watchlist Manager
Universal Health Services Inc Logo
Universal Health Services Inc
NYSE:UHS
Watchlist
Price: 186.24 USD -0.16% Market Closed
Market Cap: $11.6B

Universal Health Services Inc
Investor Relations

Universal Health Services Inc. (UHS) stands as a significant player in the healthcare industry, weaving its narrative through the intricate threads of hospital management and behavioral health services. Founded in 1979, UHS has grown into one of the largest hospital management companies in the United States. Its business model is entrenched in operating acute care hospitals, behavioral health facilities, and ambulatory care centers. These comprehensive healthcare services cater to a diverse range of patient needs, positioning UHS as a crucial component of both community healthcare and specialized medical treatment. Financially, the company's revenue streams rely heavily on patient services, including inpatient admissions and outpatient services, creating a robust network of care facilities that drive profitability and growth.

UHS doesn’t merely run hospitals; it actively invests in expanding its reach and improving its service offerings, ensuring it captures a broad market of patients needing both general and specialized medical attention. Through strategic acquisitions and maintaining high standards of care, UHS continues to bolster its operating capabilities. Its behavioral health segment, in particular, highlights the company’s commitment to addressing mental health issues, a growing concern worldwide. By optimizing operational efficiencies and leveraging its extensive infrastructure, UHS ensures continuous improvement in patient care while maintaining profitable operations. The company's bottom line is thus a reflection of its capacity to manage and integrate healthcare services seamlessly across various levels of patient interaction, ensuring sustainability and growth in a competitive industry landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 26, 2026
AI Summary
Q4 2025

Strong Q4 and FY25 Results: UHS reported fourth quarter revenue growth of 9% and full-year revenue growth of 10%, with adjusted EPS up 20% for Q4 and 31% for the year.

Expense Management: Acute care margins improved thanks to reduced contract labor and supply chain efficiency. Behavioral margins remained stable despite targeted staffing investments.

2026 Guidance: Management expects 2026 revenue of $18.4–$18.8 billion (up 6–8%), adjusted EPS of $22.64–$24.52 (up 4–13%), and 2–3% same-facility volume growth in both segments.

AI & Technology: UHS is expanding use of AI in both clinical and administrative areas, driving efficiency and reducing costs, though the financial impact is hard to quantify at this stage.

Behavioral Health Growth: Outpatient behavioral health is a key growth focus, with at least 10 new centers planned for 2026 and a strategy to diversify payer mix.

Headwinds: 2026 guidance includes $75M negative impact from reduced health insurance exchange volumes and $35M headwind from new California staffing regulations.

Share Repurchases: UHS repurchased $899 million of its shares in 2025 and maintains flexibility for both buybacks and M&A.

Analyst Q&A: Management discussed pricing trends, the impact of AI initiatives, staffing challenges, Medicaid supplementals, and expectations for stable supply costs and cash flow.

Key Financials
Net income per diluted share
$7.06
Adjusted net income per diluted share
$5.88
Same facility acute care net revenue growth
6.9%
Acute care same-facility revenue per adjusted admission
5.4%
Same facility behavioral net revenue growth
7.2%
Behavioral revenue per adjusted patient day
5.6%
Same-facility segment EBITDA margin (acute care, Q4)
14.8%
Same-facility segment EBITDA margin (acute care, full year)
15.8%
Behavioral segment headcount growth
3.1%
Cash from operating activities
$1.9B
Capital expenditures
$1B
Share repurchases
$899M (4.65M shares)
Available stock buyback authorization
$1.425B
Available borrowing capacity
$900M
Medicaid supplemental payments (2026 outlook)
$1.36B
Earnings Call Recording
Other Earnings Calls

Management

Mr. Alan B. Miller
Founder & Executive Chairman of the Board
No Bio Available
Mr. Marc D. Miller
CEO, President & Director
No Bio Available
Mr. Steve G. Filton
Executive VP, CFO & Secretary
No Bio Available
Mr. Matthew Jay Peterson
Executive VP & President of Behavioral Health Division
No Bio Available
Mr. Edward H. Sim
Executive VP & President of Acute Care Division
No Bio Available
Mr. Matthew David Klein
Senior VP & General Counsel
No Bio Available
Victor J. Radina
Senior Vice President of Corporate Development
No Bio Available
Ms. Maria Zangardi
Senior VP of Human Resources & Corporate Officer
No Bio Available
Michael S. Nelson
Senior Vice President of Strategic Services
No Bio Available
Jim Clark
Senior Vice President of Finance - Acute Care Division
No Bio Available

Contacts

Address
PENNSYLVANIA
King of Prussia
367 S Gulph Rd
Contacts
+16107683300.0
uhs.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett